Expression of Livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

181

HTML

1744

Figures (1-2)

123

Tables (1-1)

124

Sum=2172

Oct 7, 2008 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 7, 2008; 14(37): 5749-5754
Published online Oct 7, 2008. doi: 10.3748/wjg.14.5749

Table 1 Oligonucleotides used for reverse transcriptase-polymerase chain reaction

Target gene	Primer sequence (5’-3’)	Size (bp)	Annealing temperature (°C)
β-actin	Forward: GTTCGCCATGGATGACGATATC	266	59
	Reverse: GCCAGATCTTCTCCATGTCGTC
VEGF	Forward: TGCTCAGCATTCGGACTGACCT	228	61
	Reverse: CAGTATGCATGGACCATGACGG
Livin	Forward: CTGGTCAGAGCCAGTGTTCCT	312	61
	Reverse: TCATAGAAGGAGGCCAGACG

Primers were designed using the Primer Express Program and offered by AuGCT Biotechnology, Beijing, China.

Citation: Chen L, Ren GS, Li F, Sun SQ. Expression of Livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma. World J Gastroenterol 2008; 14(37): 5749-5754
URL: https://www.wjgnet.com/1007-9327/full/v14/i37/5749.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5749